Login to Your Account



Pharma: In the clinic


Friday, July 25, 2014
Bayer AG, of Leverkusen, Germany, reported results from a phase III trial testing a 15 percent foam formulation of its azelaic acid (Aza) for the topical treatment of inflammatory papules and pustules of rosacea.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription